Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more ...

The American Society of Gene & Cell Therapy (ASGCT) and Orphan Therapeutics Accelerator (OTXL) have announced the public ...

Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense ...

Korean researchers reported the discovery and preclinical characterization of KSI-028, a novel tetrahydroquinoline-based STING inhibitor with activity across multiple models of STING activation.

Sonomind SAS raised €20 million (US$23 million) in a series A funding round for its ultrasound-based neuromodulation ...

In further fallout from the COVID-19 pandemic, the EU has now reached agreement on the Critical Medicines Act, which aims to ...

Hangzhou Institute of Medicine Chinese Academy of Sciences has patented new nitrogen-containing heteroaryl compounds acting as CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.

Ensem Therapeutics Inc. has presented data for ETX-929, a small-molecule, oral pan-KRAS inhibitor with potent ON and OFF dual-state inhibitory activity for both wild-type and mutant KRAS.

After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli Lilly and Co. are advancing blockbuster glucagon-like peptide-1 (GLP-1) ...

Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage Alzheimer’s disease (AD) therapy, AR-1001. The option fee plus license ...

The number of cases of hantavirus infection has risen from eight to 11, following the repatriation of passengers from the ...

The U.S. Patent and Trademark Office (USPTO) is driving home its message that inter partes reviews (IPRs) are not to be used in conjunction with court action presenting “inconsistent positions” as a ...